MG 107 Hypoxanthine, [13C5(U), 98 atom % 13C]- Click here for Typical Certificate of Analysis |
|
|
|
|
| Solid | 1 mg $615 |
| Screw-cap v-vial | 5 mg $1930 |
|
M.W. 141.1  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 167 Hypoxanthine, [14C(U)]- Click here for Typical Certificate of Analysis |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol:water (2:98) solution, 100 µCi/ml | |
| > 230 mCi(8.51 GBq)/mmol | 10 µCi (370 kBq) $1240 |
| NextGen V-Vial | 50 µCi (1.85 MBq) $3970 |
| M.W. 136.11 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 147 Hypoxanthine, [8-14C]- |
|
| Click here for Typical Certificate of Analysis | |
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Solid | Please Inquire for Pricing |
| > 50 mCi(1.85 GBq)/mmol | |
| NextGen V-Vial | |
| M.W. 136.11 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 700 Hypoxanthine, [2,8-3H]- Click here for Typical Certificate of Analysis |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 1 mCi/ml | 1 mCi (37 MBq) $2780 |
| > 10 Ci(0.37 TBq)/mmol | 5 mCi (185 MBq) $3590 |
| NextGen V-Vial | |
| M.W. 136.11 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1732 Hypoxanthine, [8-3H]- |
|
| Click here for Typical Certificate of Analysis | |
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 1 mCi/ml | |
| > 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
M.W. 136.11
 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
